Journals / Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi / 2004 / Cilt: 50 - Sayı: 6

Evaluation of fibromyalgia in patients who were investigated for possible hormonal dysfunction

Hormonal disfonksiyon şüphesi ile tetkik edilen hastaların fibromiyalji yönünden değerlendirilmesi

Pages
3–7
Publication Date
2022-11-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

BDI scores were significantly higher in Group I (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Fibromyalgia (FM) is a disorder of unknown etiology characterized by chronic widespread musculoskeletal pain and symptoms such as fatigue, poor sleep, gastrointestinal complaints and psychological disturbances which are similar to those experienced by patients with hormonal dysfunction.
📊
Key Findings & Data:Group I included patients who fulfilled the criteria suggested by American College of Rheumatology (ACR) for the diagnosis of FM (33 patients).
💡
Conclusion & Impact:BDI scores were significantly higher in Group I (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Fibromyalgia (FM) is a disorder of unknown etiology characterized by chronic widespread musculoskeletal pain and symptoms such as fatigue, poor sleep, gastrointestinal complaints and psychological disturbances which are similar to those experienced by patients with hormonal dysfunction. Studies suggest that neuromediator and hormonal abnormalities may play an important role in the pathogenesis of FM. The aim of this study was to investigate the frequency of FM in patients with possible hormonal dysfunction.Fifty-three female patients, who applied to the Obstetrics and Gynecology, and Dermatology outpatient clinics and whose follicle stimulating hormone (FSH), luteinizing hormone (LH), prolactin (PRL), estradiol, progesterone, and testosterone levels were measured following the physical examination, were included in this study. Patients were examined, and demographic, functional and clinical characteristics were documented. Beck Depression Inventory (BDI) was used to search the level of the depressive symptoms. Group I included patients who fulfilled the criteria suggested by American College of Rheumatology (ACR) for the diagnosis of FM (33 patients). The rest of the patients were classified as Group II (20 patients). International Chronic Fatigue Syndrome (CFS) criteria were used for the differential diagnosis of CFS.Among the patients with complaints similar to those which occur in hormonal dysfunction, 62.3% matched ACR FM criteria. However, no statistically significant differences were found for the FSH, LH, PRL, estradiol, progesterone and testosterone levels between the two groups (p>0.05). BDI scores were significantly higher in Group I (p

Özet

Fibromiyalji (FM), kronik yaygın muskuloskeletal ağrı ve hormonal bozukluğu olan hastalarda görülene benzer şekilde yorgunluk, kalitesiz uyku, gastrointestinal şikayetler, psikolojik problemler gibi semptomlarla karakterize, etiyolojisi bilinmeyen bir hastalıktır. Yapılan çalışmalar nöromediatörlerin ve hormonal bozuklukların FM patogenezinde önemli bir rol oynayabileceğini düşündürmektedir. Bu çalışmanın amacı, hormonal bozukluk şüphesi olan hastaları FM yönünden değerlendirmekti.Retrospektif nitelik taşıyan bu çalışmaya hastanemiz Dermatoloji ya da Kadın Hastalıkları ve Doğum polikliniklerine başvurmuş ve muayene neticesi follikül stimülan hormon (FSH), luteinizan hormon (LH), prolaktin (PRL), östradiol, progesteron, testosteron tetkikleri değerlendirilmiş olan 53 kadın hasta alındı. Hastaların muayene bulguları, demografik, fonksiyonel ve klinik özellikleri kayıt edildi. Beck Depresyon Envanteri (BDE) ile depresif semptomların düzeyi değerlendirildi. Hastalar American College of Rheumatology (ACR) kriterlerine göre iki gruba ayrıldı; Grup I ACR kriterlerini karşılayan olgulardan (33 hasta), Grup II ise ACR kriterlerini karşılamayan olgulardan (20 hasta) oluşmaktaydı. Uluslararası Kronik Yorgunluk Sendromu (KYS) belirleme kriterleri kullanılarak KYS ayırıcı tanısı yapıldı.Hormonal problem düşündürecek şikayetlerle hastaneye başvuran hastalarda ACR FM kriterlerini karşılama oranı %62,3 (33 vaka) olarak bulundu, ancak yapılan tetkiklerde iki grup arasında FSH, LH, PRL östradiol, progesteron ve testosteron düzeyleri arasında farklılık saptanmadı (p>0,05). BDE puanı Grup I’de istatistiksel olarak anlamlı derecede yüksekti (p

🔖

Cite This Article

ESENYEL, M., ÖZARAS, N., DEMİR, E. S. (2022). Evaluation of fibromyalgia in patients who were investigated for possible hormonal dysfunction. Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi, Cilt: 50 - Sayı: 6, 3–7. https://ajindex.com/articles/629279

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Adler GK, Manfredsdottir VF, Creskoff KW. Neuroendocrine abnormalities in fibromyalgia. Curr Pain Headache Rep 2002; 6(4): 289-98
  2. Bellometti S, Galzigna L. Function of the hypothalamic adrenal axis in patients with fibromyalgia syndrome undergoing mud-pack treatment. Int J Clin Pharmacol Res 1999; 19(1): 27-33
  3. Neeck G, Riedel W. Hormonal perturbations in fibromyalgia syndrome. Ann N Y Acad Sci 1999; 876: 325-38
  4. Schochat T, Beckmann C. Sociodemographic characteristics, risk factors and reproductive history in subjects with fibromyalgia - results of a population-based case-control study. Z Rheumatol 2003; 62(1): 46-59
  5. Ostensen M, Rugelsjoen A, Wigers SH. The effect of reproductive events and alterations of sex hormone levels on the symptoms of fibromyalgia. Scand J Rheumatol 1997; 26: 355-60
  6. Wolfe F, Smyte H, Yunus M, Bennett RM, et al. 1990 The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of multicenter criteria committee. Arthritis Rheum 1990; 33: 160-72
  7. Gür A, Karakoç M, Nas K, Cevik R, et al. Effects of low power laser and low dose amitriptyline therapy on clinical symptoms and quality of life in fibromyalgia: a single-blind, placebo-controlled trial. Rheumatol Int 2002; 22: 188-93
  8. Fukuda K, Straus S, Hickie I, Sharpe MC, et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med 1994; 121: 953-9
  9. Bennet RM. Confounding features of fibromyalgia syndrome: a current perspective of differential diagnosis. J Rheumatol 1989; Suppl 19: 58-61
  10. Cathey MA, Wolfe F, Kleinheksel SM, Hawley DJ. Socioeconomic impact of fibrositis. A study of 81 patients with primary fibrositis. Am J Med 1986; 81: 78-84
  11. Hapidou EG, Rollman GB. Menstrual cycle modulation of tender points. Pain 1998; 77(2): 151-61
  12. Geenen R, Jacobs JW, Bijlsma JW. Evaluation and management of endocrine dysfunction in fibromyalgia. Rheum Dis Clin North Am 2002; 28(2): 389-404
  13. Akkus S, Delibas N, Tamer MN. Do sex hormones play a role in fibromyalgia? Rheumatology 2000; 39: 1161-3
  14. Riedel W, Layka H, Neeck G. Secretory pattern of GH, TSH, thyroid hormones, ACTH, cortisol, FSH, and LH in patients with fibromyalgia syndrome following systemic injection of the relevant hypothalamic-releasing hormones. Z Rheumatol 1998; 57(Suppl. 2): 81-7
  15. Korszun A, Young EA, Engleberg NC, Masterson L, et al. Follicular phase hypothalamic-pituitary-gonadal axis function in